Jefferies Group LLC Marker Therapeutics, Inc. Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$2.68 - $4.85 $27,928 - $50,541	-10,421 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$4.1 - $9.0 $42,726 - $93,789	10,421 New	10,421 $53,000
Q2 2019 Aug 14, 2019	SELL	$5.15 - $7.92 $104,030 - $159,984	-20,200 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.1 - $6.71 $103,020 - $135,542	20,200 New	20,200 $133,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $206M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.